pharmaceuticals-and-healthcare

Asia-Pacific RNA-Based Vaccines Market Report 2017


Published On : Aug 2017

Category : Pharmaceutical

No. of Pages : 111 pages

  • $4000
  • $8000

Please click below to avail discount on this report

Table of Contents

Asia-Pacific RNA-Based Vaccines Market Report 2017
1 RNA-Based Vaccines Overview
1.1 Product Overview and Scope of RNA-Based Vaccines
1.2 Classification of RNA-Based Vaccines by Product Category
1.2.1 Asia-Pacific RNA-Based Vaccines Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific RNA-Based Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.1 Type I
1.2.2 Type II
1.3 Asia-Pacific RNA-Based Vaccines Market by Application/End Users
1.3.1 Asia-Pacific RNA-Based Vaccines Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Asia-Pacific RNA-Based Vaccines Market by Region
1.4.1 Asia-Pacific RNA-Based Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of RNA-Based Vaccines (2012-2022)
1.5.1 Asia-Pacific RNA-Based Vaccines Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate (2012-2022)

2 Asia-Pacific RNA-Based Vaccines Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific RNA-Based Vaccines Market Competition by Players/Suppliers
2.1.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific RNA-Based Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific RNA-Based Vaccines (Volume and Value) by Type
2.2.1 Asia-Pacific RNA-Based Vaccines Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific RNA-Based Vaccines Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific RNA-Based Vaccines (Volume) by Application
2.4 Asia-Pacific RNA-Based Vaccines (Volume and Value) by Region
2.4.1 Asia-Pacific RNA-Based Vaccines Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific RNA-Based Vaccines Revenue and Market Share by Region (2012-2017)

3 China RNA-Based Vaccines (Volume, Value and Sales Price)
3.1 China RNA-Based Vaccines Sales and Value (2012-2017)
3.1.1 China RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
3.1.2 China RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
3.1.3 China RNA-Based Vaccines Sales Price Trend (2012-2017)
3.2 China RNA-Based Vaccines Sales Volume and Market Share by Type
3.3 China RNA-Based Vaccines Sales Volume and Market Share by Application

4 Japan RNA-Based Vaccines (Volume, Value and Sales Price)
4.1 Japan RNA-Based Vaccines Sales and Value (2012-2017)
4.1.1 Japan RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
4.1.3 Japan RNA-Based Vaccines Sales Price Trend (2012-2017)
4.2 Japan RNA-Based Vaccines Sales Volume and Market Share by Type
4.3 Japan RNA-Based Vaccines Sales Volume and Market Share by Application

5 South Korea RNA-Based Vaccines (Volume, Value and Sales Price)
5.1 South Korea RNA-Based Vaccines Sales and Value (2012-2017)
5.1.1 South Korea RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
5.1.3 South Korea RNA-Based Vaccines Sales Price Trend (2012-2017)
5.2 South Korea RNA-Based Vaccines Sales Volume and Market Share by Type
5.3 South Korea RNA-Based Vaccines Sales Volume and Market Share by Application

6 Taiwan RNA-Based Vaccines (Volume, Value and Sales Price)
6.1 Taiwan RNA-Based Vaccines Sales and Value (2012-2017)
6.1.1 Taiwan RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan RNA-Based Vaccines Sales Price Trend (2012-2017)
6.2 Taiwan RNA-Based Vaccines Sales Volume and Market Share by Type
6.3 Taiwan RNA-Based Vaccines Sales Volume and Market Share by Application

7 India RNA-Based Vaccines (Volume, Value and Sales Price)
7.1 India RNA-Based Vaccines Sales and Value (2012-2017)
7.1.1 India RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
7.1.2 India RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
7.1.3 India RNA-Based Vaccines Sales Price Trend (2012-2017)
7.2 India RNA-Based Vaccines Sales Volume and Market Share by Type
7.3 India RNA-Based Vaccines Sales Volume and Market Share by Application

8 Southeast Asia RNA-Based Vaccines (Volume, Value and Sales Price)
8.1 Southeast Asia RNA-Based Vaccines Sales and Value (2012-2017)
8.1.1 Southeast Asia RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia RNA-Based Vaccines Sales Price Trend (2012-2017)
8.2 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Type
8.3 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Application

9 Australia RNA-Based Vaccines (Volume, Value and Sales Price)
9.1 Australia RNA-Based Vaccines Sales and Value (2012-2017)
9.1.1 Australia RNA-Based Vaccines Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia RNA-Based Vaccines Revenue and Growth Rate (2012-2017)
9.1.3 Australia RNA-Based Vaccines Sales Price Trend (2012-2017)
9.2 Australia RNA-Based Vaccines Sales Volume and Market Share by Type
9.3 Australia RNA-Based Vaccines Sales Volume and Market Share by Application

10 Asia-Pacific RNA-Based Vaccines Players/Suppliers Profiles and Sales Data
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 RNA-Based Vaccines Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Roche
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 RNA-Based Vaccines Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Sanofi-Aventis
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 RNA-Based Vaccines Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 RNA-Based Vaccines Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Arrowhead Pharmaceuticals
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 RNA-Based Vaccines Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Benitec Biopharma
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 RNA-Based Vaccines Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Calimmune Inc
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 RNA-Based Vaccines Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Dicerna
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 RNA-Based Vaccines Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Gradalis
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 RNA-Based Vaccines Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Quark
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 RNA-Based Vaccines Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 RXi
10.12 Senesco
10.13 Silence Therapeutics
10.14 Silenseed
10.15 Tekmira
10.16 Alnylam Pharmaceuticals

11 RNA-Based Vaccines Manufacturing Cost Analysis
11.1 RNA-Based Vaccines Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of RNA-Based Vaccines

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 RNA-Based Vaccines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific RNA-Based Vaccines Market Forecast (2017-2022)
15.1 Asia-Pacific RNA-Based Vaccines Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific RNA-Based Vaccines Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific RNA-Based Vaccines Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific RNA-Based Vaccines Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia RNA-Based Vaccines Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific RNA-Based Vaccines Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific RNA-Based Vaccines Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific RNA-Based Vaccines Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific RNA-Based Vaccines Price Forecast by Type (2017-2022)
15.4 Asia-Pacific RNA-Based Vaccines Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer


Back To Top